Medically Tailored Meals for Type 2 Diabetes
(FAME-D Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
The investigators propose a single-site, open-label, Phase II, community-based randomized clinical explanatory trial to test the efficacy of a medically tailored meal (MTM) interventions for adults with food insecurity and T2DM (Type 2 Diabetes Mellitus). While the efficacy of MTM needs to be established, given the nature of the population served by MTM, it is important to design the study to enhance the external validity/generalizability of the findings as much as possible. The investigators will recruit 200 participants from the referral list of Community Servings, a Boston-based MTM provider, and randomly assign them to MTM (N=100) or usual care + monthly food subsidy (N=100). MTM intervention will consist of 6 months of weekly delivery of 10 ready-to-eat meals (approximately half an individual's weekly food intake), along with telephone-based lifestyle intervention that prepares participants for the post-treatment period. The usual care + food subsidy recipients will receive usual care along with 6 months of a $40/month food subsidy.
Do I have to stop taking my current medications for this trial?
The trial protocol does not specify if you need to stop taking your current medications. However, if you intermittently use medications like glucocorticoids that affect blood sugar, you may not be eligible to participate.
Will I have to stop taking my current medications?
The trial information does not specify if you need to stop taking your current medications. However, if you use medications like glucocorticoids that affect blood sugar, you might not be eligible to participate.
What safety data exists for medically tailored meals for type 2 diabetes?
The provided research does not explicitly mention safety data for medically tailored meals (MTM) for type 2 diabetes. However, the studies suggest that MTM interventions are beneficial in managing chronic conditions like type 2 diabetes, improving health outcomes, and reducing healthcare costs. Further studies are needed to validate these findings and potentially support policy changes for insurance coverage.12345
Are medically tailored meals safe for humans?
Medically tailored meals (MTM) have been used in various studies and are generally considered safe for humans. They are designed to provide nutritious, pre-prepared meals to help manage chronic conditions like type 2 diabetes, and no specific safety concerns have been reported in the research available.12345
Is the treatment Food As Medicine a promising treatment for Type 2 Diabetes?
Yes, Food As Medicine, which includes Medically Tailored Meals, is a promising treatment for Type 2 Diabetes. It helps improve the health of people who struggle to get enough nutritious food and can lower healthcare costs. This approach involves providing healthy, pre-prepared meals to manage diabetes better.12345
How is the treatment of medically tailored meals unique for type 2 diabetes?
Medically tailored meals (MTM) are unique because they involve healthcare providers prescribing pre-prepared meals specifically designed to meet the nutritional needs of individuals with type 2 diabetes, especially those who struggle to access nutritious food. This approach not only helps manage the condition but also reduces healthcare costs by improving overall health and reducing hospital visits.12345
What data supports the idea that Medically Tailored Meals for Type 2 Diabetes is an effective treatment?
The available research shows that Medically Tailored Meals (MTM) can be effective for people with Type 2 Diabetes, especially those who struggle to access nutritious food. These meals help improve health and reduce healthcare costs for food-insecure patients. Participants in MTM programs reported being able to eat the right foods, which suggests that these meals help manage diabetes better than usual care. While more studies are needed, the current evidence supports the idea that MTM can be a valuable treatment option for managing Type 2 Diabetes.12345
What data supports the effectiveness of the treatment Medically Tailored Meals for Type 2 Diabetes?
Who Is on the Research Team?
Seth Berkowitz, MD
Principal Investigator
UNC
Are You a Good Fit for This Trial?
This trial is for adults with food insecurity and Type 2 Diabetes Mellitus who speak English, plan to stay in the area for a year, have specific levels of Hemoglobin A1c and BMI, can control their diet, consent to participate, and aren't planning pregnancy. Excluded are those with severe psychiatric issues or substance misuse, involved in similar research recently, without stable housing or phone access, certain medical conditions including advanced kidney disease or recent cancer (except some localized cases).Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive medically tailored meals (MTM) with weekly delivery and a telephone-based lifestyle intervention for 6 months
Follow-up
Participants are monitored for diabetes self-care activities and other health outcomes after the treatment period
What Are the Treatments Tested in This Trial?
Interventions
- Food As Medicine
Food As Medicine is already approved in United States for the following indications:
- Type 2 Diabetes Mellitus (T2DM)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of North Carolina, Chapel Hill
Lead Sponsor
Community Servings
Collaborator
Community Servings
Collaborator
Massachusetts General Hospital
Collaborator
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator